IHS Chemical Week

People & Business :: M&A

Bayer receives FTC clearance for Conceptus acquisition

May 29, 2013 | Natasha Alperowicz

Bayer has received clearance from US FTC to acquire contraceptive device maker Conceptus (Mountain View, CA), Bayer said today. The FTC raised no objection to the transaction within the relevant waiting period under US antitrust law, which expired on Tuesday. The antitrust clearance marks an important step in Bayer’s intended acquisition of Conceptus. The transaction remains conditioned upon a minimum tender of at least a majority of the outstanding shares of Conceptus. On 7 May, Evelyn Acquisition, a subsidiary established by Bayer HealthCare (Tarrytown...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa